Evasion of host defences by tumours (Q39679313)

13 September 2017

title

Evasion of host defences by tumours (English)

1 reference

13 September 2017

Nelson DS

1

1 reference

13 September 2017

Nelson M

series ordinal

2

1 reference

13 September 2017

publication date

1 August 1987

1 reference

Immunology & Cell Biology

13 September 2017

language of work or name

English

0 references

published in

1 reference

13 September 2017

volume

65 ( Pt 4)

1 reference

13 September 2017

page(s)

287-304

1 reference

publication type of scholarly work

13 September 2017

review article

1 reference

Natural killer cells: their roles in defenses against disease

cites work

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

The Cell Biology of Macrophage Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Immunoresistant metastatic tumor variants can re-express their tumor antigen after treatment with DNA methylation-inhibiting agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

The use of monoclonal antibody conjugates for the diagnosis and treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Specificity of tumour associated transplantation antigens (TATA) of different clones from the same tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Genetic restriction of the serum factor mediating tolerance in trinitrochlorobenzene hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Thy and Ly markers on lymphocytes initiating tumor rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Low dose tolerance preventing tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

"Sneaking through": a T-cell-dependent phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Induction of tolerance to a murine fibrosarcoma in two zones of dosage--the involvement of suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Systemic and in situ natural killer and suppressor cell activities in mice bearing progressively growing murine sarcoma-virus-induced tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Prostaglandin-Producing Suppressor Cells in Hodgkin's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Abnormal monocyte function in patients with Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

An overview of T-suppressor cell circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Accessory cell-dependent selection of specific T-cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Interleukin 2 (IL-2) activity during tumor growth: IL-2 production kinetics, absorption of and responses to exogenous IL-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Macrophage infiltration and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Abnormal Monocyte Chemotactic Response in Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Abnormalities of Monocyte Chemotaxis in Patients With Melanoma: Effects of Immunotherapy and Tumor Removal2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Defects in monocyte chemotaxis in patients with neoplastic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Cytolytic and cytostatic activity on tumor cells of circulating human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Macrophage content and colony-forming potential in mouse mammary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Immunosuppressive activity of the retroviral envelope protein P 15E and its possible relationship to neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

The LDH Virus: An Interfering Biological Contaminant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Inhibition of the lymphocyte blastogenic response to antigen by serum-free culture supernatants of leukemic B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Immunomodulating activity in supernatants from EBV immortalized lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Macrophage deactivation. Altered kinetic properties of superoxide-producing enzyme after exposure to tumor cell-conditioned medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Chemotactic activity for mononuclear phagocytes of culture supernatants from murine and human tumor cells: evidence for a role in the regulation of the macrophage content of neoplastic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Interleukin-2 production in head and neck cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Absence of generalized immunosuppression in C57BL/6J mice implanted with Lewis T241 fibrosarcoma or Lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Inhibition of lymphocyte mitogenesis by factor(s) released from macrophages isolated from ascitic fluid of advanced ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Activation of suppressor cells by low molecular weight factors secreted by spleen cells of tumor-bearing mice: modulatory role of prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Inhibitors of monocyte responses to chemotaxins are present in human cancerous effusions and react with monoclonal antibodies to the P15(E) structural protein of retroviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Murine malignant cells synthesize a 19,000-dalton protein that is physicochemically and antigenically related to the immunosuppressive retroviral protein, P15E

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Human malignant and mitogen-transformed cells contain retroviral P15E-related antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Immunotherapy of bovine ocular squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

The molecular genetics of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Malignancy and haemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Lymphokine-induced monocyte procoagulant activity is depressed in patients with advanced malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

An analysis of the factors allowing promotion (rather than inhibition) of tumour growth by Corynebacterium parvum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Effect of X-irradiation on host-cell infiltration and growth of a murine fibrosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Properties of reticulum cell sarcomas in SJL/J mice. III. Promotion of tumor growth in irradiated mice by normal lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Effect of hydrocortisone on the macrophage content, growth and metastasis of transplanted murine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Augmentation of specific immune response against a syngeneic SV40-induced sarcoma in mice by depletion of suppressor T cells with cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Immunostimulation of the Lymphodependent Phase of Neoplastic Growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

A significant part of macrophage-derived growth factor consists of at least two forms of PDGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Failure of immunogenic tumors to elicit cytolytic T cells in syngeneic hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

The negative systemic effect of BCGcw inoculated intraperitoneally

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

Facilitation of Rat Mammary Tumour Growth by BCG

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Concomitant immunity to syngeneic methylcholanthrene-induced tumours in mice. Occurrence and specificity of concomitant immunity

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Concomitant Tumor Immunity and the Resistance to a Second Tumor Challenge

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

In vitro assays of cell-mediated immunity to human solid tumors: problems of quantitation, specificity, and interpretation

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Problems Associated With Study of Cell-Mediated Immunity to Human Tumors by Microcytotoxicity Assays

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Production of stable cytolytic T-cell clones directed against autologous human melanoma

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Loss of HLA-A,B,C and de novo expression of HLA-D in colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Expression of HLA-D sub-region products on human colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Further characterization of the cells involved in leukocyte adherence inhibition with murine tumor extracts

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Leucocyte adherence inhibition test for the detection of cell-mediated immunity to malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

The genetic and cellular basis of regulation of the immune response to tumor antigens

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Macrophage activation during experimental murine brucellosis. III. Do macrophages exert feedback control during brucellosis?

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Monocyte and lymphocyte interaction in patients with advanced cancer. Evidence for deficient IL-1 production

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Suppressive effect of monocytes in vitro in patients with carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Tumor enhancing T lymphocytes in mice: further studies on characteristics and mechanism of activity

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Cell-mediated suppression of tumor immunity has a non-specific component. I. Evidence from transplantation tests

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Cell-mediated suppression of tumor immunity has a non-specific component. II. Evidence from cell culture experiments

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Suppressor cell activity in melanoma patients. I. Relation to tumor growth an immunoglobulin levels in vivo

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Suppressor cell activity in melanoma patients. II. Concanavalin A-induced suppressor cells in relation to tumor growth and suppressor T-cell subsets

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

The generation of interleukin-2-dependent suppressor T-cells from patients with systemic metastasis of gastric carcinoma and the phenotypic characterization of the cells defined by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Is immunological tolerance (non-responsiveness) a consequence of interleukin 2 deficit during the recognition of antigen?

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Cancer and subversion of host defences.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

The role of macrophages in defense against neoplastic disease

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Immunosuppression and the Role of Suppressive Factors in Cancer

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

A high macrophage content in human breast cancer is not associated with favourable prognostic factors

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Macrophages and resistance to tumors. IV. Influence of age on susceptibility of mice to anti-inflammatory and antimacrophage effects of tumor cell products

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Effects of tumour cell culture supernatants on some biochemical activities of macrophages

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Mycoplasma contamination: a hazard of screening hybridoma supernatants for inhibition of [3H]thymidine incorporation

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Immunosuppression by human skin cancers.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Defective interleukin-1 production by monocytes from patients with malignant disease. Interferon increases IL-1 production

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Defective interleukin-1 production by natural killer cells of patients with cancer

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Modulation of interleukin-1 production by macrophages following benzo(a)pyrene exposure

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Inhibitory factors derived from human tumors: isolation of factors which suppress macrophage mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Enhancement of production of superoxide anion by human monocytes exposed to products of HT 29 human colonic adenocarcinoma cell line

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

A macrophage-derived factor that inhibits the production and action of interleukin 2

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

The effects of indomethacin and interleukin-2 on the proliferation of lymphocytes from patients with lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Production of and response to interleukin-2 in peripheral blood lymphocytes of cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

The immune system during the pre-cancer and the early cancer period. IL-2 production by PBL from post-menopausal women with and without endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

In vivo assessment of tumor-induced nonspecific suppression of contact sensitivity. II. Regulation by cytokines and T cells via adoptive transfer

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Requirement for prostaglandin E1 (PGE1) for the secretion of suppressor cell inducer factors by spleen cells of tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Depression of cell-mediated immunity by tumour cell products: induction of resistance by immunotherapeutically active extracts of bovine ocular squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Identification and characterization of a tumor-derived immunosuppressive glycoprotein from murine melanoma K-1735

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Suppression of both macrophage-mediated tumor cell lysis and cytolytic factor production by a factor (CIF) derived from normal embryonic fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Tumor shedding and coagulation

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Role of nk cells in the antimetastatic effect of anticoagulant drugs

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Analysis of the inhibition of tumour metastasis by sulphated polysaccharides

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

The dose-response curve in tumor-immunity

1 reference

https://api.crossref.org/works/10.1038%2FICB.1987.33

7 January 2021

Identifiers

DOI

10.1038/ICB.1987.33

1 reference

13 September 2017

1 reference